MC2 Therapeutics Announces Approval of Wynzora® Cream in Canada
POSTED: December 19, 2025
MC2 Therapeutics Announces Approval of Wynzora® Cream in Canada
Copenhagen, December 18, 2026 – MC2 Therapeutics, a commercial-stage pharmaceutical company focused on topical therapies in inflammatory skin conditions, today announced that their ...
READ FULL ARTICLE >
MC2 Therapeutics Appoints Trine Ahlgreen as New CEO
POSTED: May 27, 2025
Copenhagen, May 27th, 2025 – MC2 Therapeutics, a commercial-stage pharmaceutical company focused on topical therapies in inflammatory skin conditions, today announced the appointment of Trine Ahlgreen as Chief Executive Officer, marking ...
READ FULL ARTICLE >